Başcı, S. Et Al. 2020. Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors. Journal of Oncology Pharmacy Practice , vol.26, no.7 , 1676-1682.

Başcı, S., Ata, N., ALTUNTAŞ, F., Yiğenoğlu, T. N., Dal, M. S., Korkmaz, S., ... Namdaroğlu, S.(2020). Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors. Journal of Oncology Pharmacy Practice , vol.26, no.7, 1676-1682.

Başcı, SEMİH Et Al. "Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors," Journal of Oncology Pharmacy Practice , vol.26, no.7, 1676-1682, 2020

Başcı, SEMİH Et Al. "Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors." Journal of Oncology Pharmacy Practice , vol.26, no.7, pp.1676-1682, 2020

Başcı, S. Et Al. (2020) . "Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors." Journal of Oncology Pharmacy Practice , vol.26, no.7, pp.1676-1682.

@article{article, author={SEMİH BAŞCI Et Al. }, title={Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors}, journal={Journal of Oncology Pharmacy Practice}, year=2020, pages={1676-1682} }